Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
With
United States Department of Defense
Genentech, Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women age \> 18
Biopsy proven HER2 negative primary breast cancer and biopsy proven metastatic disease.
5 or more foci of demonstrable metastases on recent imaging modalities (CT, MR, FDG PET/CT)
ECOG performance score of 0-2
You may not be if
Life expectancy \< 3months
Pregnancy or lactation
Patients who cannot undergo PET/CT scanning because of weight limits
CNS only disease on recent imaging
Clareo Health | Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
